Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary reveals positive financial performance with improved margins, increased EBITDA, and a shift from net loss to net income. The Q&A section highlights strong RFP activity, a diversified customer base, and a positive outlook for the Contact Centers. Despite some uncertainties, such as tariff refunds and strategy shifts in Healthcare Apparel, the overall sentiment remains positive. The company's proactive approach to cost management and growth in key segments suggests a likely positive stock price movement in the short term, especially with the anticipated sequential improvement in Contact Centers.
First Quarter Revenue $141 million, up 3% year-over-year. The increase was attributed to growth in Branded Products and Healthcare Apparel segments.
Branded Products Revenue $91 million, up 5% year-over-year. Growth driven by volume gains within existing customer accounts.
Healthcare Apparel Revenue $29 million, up 5% year-over-year. Growth driven by volume growth in existing wholesale accounts and progress in direct-to-consumer.
Contact Centers Revenue $22 million, down 8% year-over-year. Decline due to prior year client attrition, though sequential improvement was noted from the fourth quarter.
Gross Margin Rate 37.1%, improved by 30 basis points year-over-year. Improvement attributed to better customer mix in Branded Products.
Branded Products Gross Margin 34.1%, up 210 basis points year-over-year. Improvement due to weaker margin related to customer mix in the prior year.
Healthcare Apparel Gross Margin 35.6%, down 160 basis points year-over-year. Decline due to growth with lower-margin customers.
Contact Centers Gross Margin 52.2%, down 140 basis points year-over-year. Decline due to higher labor costs.
SG&A as a Percent of Sales 35.8%, improved from 36.5% year-over-year. Improvement reflects cost reduction efforts.
EBITDA $4.8 million, up from $3.5 million year-over-year. EBITDA margin improved by 80 basis points to 3.4%, driven by cost management and revenue growth.
Net Income $800,000, compared to a net loss of $800,000 in the prior year. Improvement driven by higher revenue and better cost management.
Diluted EPS $0.06, compared to a $0.05 loss per share in the prior year. Improvement reflects overall better financial performance.
Operating Cash Flow $9 million generated in the quarter, building on $20 million produced in 2025.
Cash and Cash Equivalents $23 million at the end of March, reflecting strong liquidity.
Branded Products Revenue Growth: Revenue grew 5% year-over-year for the second quarter in a row, driven by volume gains within existing customer accounts. Gross margin improved, and SG&A was held near 27% of sales, supporting EBITDA growth.
Healthcare Apparel Revenue Growth: Revenue grew 5% versus last year's first quarter, driven by volume growth in existing wholesale accounts and progress in direct-to-consumer channels. New leadership and strategies are in place to improve execution.
Contact Centers Revenue Decline: Revenue declined 8% year-over-year due to prior year client attrition but improved sequentially from the fourth quarter. The opportunity pipeline remains historically high, and efforts are focused on converting this into growth.
Gross Margin Improvement: Consolidated gross margin rate improved by 30 basis points to 37.1% for the first quarter. Branded Products gross margin increased by 210 basis points, while Healthcare Apparel and Contact Centers saw slight declines due to customer mix and labor costs, respectively.
SG&A Efficiency: SG&A as a percent of sales improved to 35.8% compared to 36.5% last year, reflecting cost control measures and efficiency improvements.
EBITDA Growth: EBITDA increased to $4.8 million from $3.5 million last year, with an 80 basis point improvement in EBITDA margin to 3.4%.
Leadership Change in Healthcare Apparel: Chris Hein was appointed as President of the Healthcare Apparel segment, bringing extensive multichannel apparel experience to drive results and improve execution.
AI and Technology Implementation in Contact Centers: Continued focus on implementing AI and other technologies contributed to cost reductions and improved margin rates in the Contact Centers segment.
Market Uncertainty: The environment remains uncertain, including added uncertainty around the Iran conflict, which could impact the company's operations and strategic execution.
Segment-Specific Challenges: The Contact Centers segment experienced an 8% revenue decline year-over-year due to prior year client attrition, which could affect overall financial performance.
Margin Pressures: Healthcare Apparel gross margin rate declined by 160 basis points due to growth with lower-margin customers, and Contact Centers gross margin decreased by 140 basis points due to higher labor costs.
Labor Costs: Higher labor costs in the Contact Centers segment negatively impacted gross margins, posing a challenge to profitability.
Customer Mix: Healthcare Apparel segment faced margin pressures due to growth with lower-margin customers, which could impact profitability.
Revenue Growth: The company expects 2026 net sales to range between $572 million and $585 million, reflecting a meaningful improvement compared to the $0.46 EPS generated last year.
Earnings Per Share (EPS): Diluted EPS for 2026 is projected to be between $0.54 and $0.66, with results expected to be weighted toward the back half of the year.
Segment Contributions: All three segments (Branded Products, Healthcare Apparel, and Contact Centers) are expected to contribute to the company's growth trajectory in 2026.
Sequential Improvement: The business is anticipated to show sequential improvement throughout the year, consistent with historical trends.
Investment in Growth: The company plans to continue investing in sales talent, marketing, and sales technology to support future growth.
Profitability: Gross margin rate improved by 30 basis points in Q1 2026, and the company expects continued focus on cost management and margin improvement.
Dividend Payment: During the quarter, the company paid $2 million in dividends.
Share Repurchase: The company repurchased $700,000 worth of stock during the quarter.
Remaining Authorization: The company has $9.4 million still available under its share repurchase authorization.
The earnings call summary reveals positive financial performance with improved margins, increased EBITDA, and a shift from net loss to net income. The Q&A section highlights strong RFP activity, a diversified customer base, and a positive outlook for the Contact Centers. Despite some uncertainties, such as tariff refunds and strategy shifts in Healthcare Apparel, the overall sentiment remains positive. The company's proactive approach to cost management and growth in key segments suggests a likely positive stock price movement in the short term, especially with the anticipated sequential improvement in Contact Centers.
The earnings call summary shows positive financial performance with a 5% revenue increase, improved gross margins, and higher net income. Strategic initiatives and a strong outlook further support this sentiment. The Q&A section did not reveal any significant negative concerns. Overall, the financial health and growth prospects suggest a positive stock price movement.
The earnings report shows mixed results: a decline in revenue and margins, but cost savings and a strong Branded Products pipeline. Despite negative trends in the Contact Center and declining EBITDA, optimistic guidance for revenue growth in Q4 and potential acquisitions provide balance. The Q&A highlights challenges in client retention and tariff impacts, but also potential revenue normalization. Without market cap data, the net effect suggests a neutral stock movement, as the positive and negative factors seem to offset each other.
The earnings call reflects strong financial performance with increased net income and decreased net interest expense. Product development shows potential with AI integration, and market strategy is optimistic despite some uncertainties. Management's reiteration of revenue guidance and successful tariff mitigation efforts are positive indicators. Shareholder return plans are not explicitly mentioned, but overall, the sentiment is positive with a focus on growth and cost efficiency.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.